These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 34462268)

  • 21. Pharmacokinetics of TDP223206 following intravenous and oral administration to intact rats and intravenous administration to bile duct-cannulated rats.
    Chen Y; Cheng D; Marugan JJ; Manthey C; Tomczuk B; Huebert N
    Biopharm Drug Dispos; 2008 May; 29(4):219-30. PubMed ID: 18260095
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Disposition and metabolism of the new hypocholesterolemic compound S-8921 in rats and dogs.
    Yamaguchi T; Nakajima Y; Mizobuchi M; Inazawa K; Kanazu T; Kadono K; Ohkawa T; Iwatani K
    Arzneimittelforschung; 1998 Oct; 48(10):995-1006. PubMed ID: 9825117
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Disposition of a low dose of 14C-bisphenol A in male rats and its main biliary excretion as BPA glucuronide.
    Kurebayashi H; Betsui H; Ohno Y
    Toxicol Sci; 2003 May; 73(1):17-25. PubMed ID: 12700409
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Biotransformation of a GABAA receptor partial agonist in sprague-dawley rats and cynomolgus monkeys: identification of two unique N-carbamoyl metabolites.
    Shaffer CL; Gunduz M; O'Connell TN; Obach RS; Yee S
    Drug Metab Dispos; 2005 Nov; 33(11):1688-99. PubMed ID: 16081672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Application of ultrasound-guided cholecystocentesis to the evaluation of the metabolite profiling in bile of dogs and cynomolgus monkeys.
    Dierks EA; Luk CE; Cai H; MacGuire J; Fox M; Smalley J; Fancher RM; Janovitz E; Foster K; Sun Q
    Pharmacol Res Perspect; 2019 Jun; 7(3):e00488. PubMed ID: 31149343
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maribavir: a novel antiviral agent with activity against cytomegalovirus.
    Trofe J; Pote L; Wade E; Blumberg E; Bloom RD
    Ann Pharmacother; 2008 Oct; 42(10):1447-57. PubMed ID: 18698013
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolism and disposition of the DOT1L inhibitor, pinometostat (EPZ-5676), in rat, dog and human.
    Waters NJ; Smith SA; Olhava EJ; Duncan KW; Burton RD; O'Neill J; Rodrigue ME; Pollock RM; Moyer MP; Chesworth R
    Cancer Chemother Pharmacol; 2016 Jan; 77(1):43-62. PubMed ID: 26645404
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys.
    Tan EY; Hartmann G; Chen Q; Pereira A; Bradley S; Doss G; Zhang AS; Ho JZ; Braun MP; Dean DC; Tang W; Kumar S
    Drug Metab Dispos; 2010 Mar; 38(3):459-73. PubMed ID: 20016052
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Species difference in glucuronidation formation kinetics with a selective mTOR inhibitor.
    Berry LM; Liu J; Colletti A; Krolikowski P; Zhao Z; Teffera Y
    Drug Metab Dispos; 2014 Apr; 42(4):707-17. PubMed ID: 24423753
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Orally active inhibitors of human leukocyte elastase. I. Disposition of L-683,845 in rats and rhesus monkeys.
    Vincent SH; Painter SK; Krieter PA; Colletti AE; Lyszack E; Rosegay A; Dean D; Luffer-Atlas D; Miller RR; Cioffe C; Chiu SH
    Drug Metab Dispos; 1996 Dec; 24(12):1369-77. PubMed ID: 8971144
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biliary excretion and enterohepatic recirculation of morphine-3-glucuronide in rats.
    Ouellet DM; Pollack GM
    Drug Metab Dispos; 1995 Apr; 23(4):478-84. PubMed ID: 7600915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Predicting the pharmacokinetics of acyl glucuronides and their parent compounds in disease states.
    Liu JH; Smith PC
    Curr Drug Metab; 2006 Feb; 7(2):147-63. PubMed ID: 16472105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacokinetics of the new thyrotropin releasing hormone analogue montirelin hydrate. 1st communication: plasma concentrations, metabolism and excretion after a single intravenous administration to rats, dogs and monkeys.
    Sugimoto T; Hayashi T; Okita A; Morino A
    Arzneimittelforschung; 1996 Feb; 46(2):106-13. PubMed ID: 8720298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model.
    Marier JF; Vachon P; Gritsas A; Zhang J; Moreau JP; Ducharme MP
    J Pharmacol Exp Ther; 2002 Jul; 302(1):369-73. PubMed ID: 12065739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disposition of the dipeptidyl peptidase 4 inhibitor sitagliptin in rats and dogs.
    Beconi MG; Reed JR; Teffera Y; Xia YQ; Kochansky CJ; Liu DQ; Xu S; Elmore CS; Ciccotto S; Hora DF; Stearns RA; Vincent SH
    Drug Metab Dispos; 2007 Apr; 35(4):525-32. PubMed ID: 17220241
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo disposition and metabolism of 3'-deoxy-2',3'-didehydrothymidine.
    Cretton EM; Zhou Z; Kidd LB; McClure HM; Kaul S; Hitchcock MJ; Sommadossi JP
    Antimicrob Agents Chemother; 1993 Sep; 37(9):1816-25. PubMed ID: 8239589
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bile flow but not enterohepatic recirculation influences the pharmacokinetics of ranitidine in the rat.
    Suttle AB; Brouwer KL
    Drug Metab Dispos; 1994; 22(2):224-32. PubMed ID: 8013278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolism and ocular tissue distribution of an antiglaucoma prostanoid, tafluprost, after ocular instillation to monkeys.
    Fukano Y; Kawazu K; Akaishi T; Bezwada P; Pellinen P
    J Ocul Pharmacol Ther; 2011 Jun; 27(3):251-9. PubMed ID: 21491995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics and metabolism of KW-4490, a selective phosphodiesterase 4 inhibitor: difference in excretion of KW-4490 and acylglucuronide metabolites between rats and cynomolgus monkeys.
    Fujita K; Kodaira H; Kuwabara T; Kobayashi H
    Xenobiotica; 2008 May; 38(5):511-26. PubMed ID: 18421624
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of verapamil on the pharmacokinetics and hepatobiliary disposition of fexofenadine in pigs.
    Sjögren E; Hedeland M; Bondesson U; Lennernäs H
    Eur J Pharm Sci; 2014 Jun; 57():214-23. PubMed ID: 24075962
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.